5-HIAA

Also known as: HIAA; Serotonin metabolite

Formal name: 5-hydroxyindoleacetic acid

Related tests: Serotonin; Chromogranin A

At a Glance

Why Get Tested?

To help diagnose and monitor treatment for a serotonin-secreting carcinoid tumor

When to Get Tested?

When you have symptoms suggestive of a carcinoid tumor such as flushing, diarrhea, and/or wheezing, and at intervals following treatment

Sample Required?

A 24-hour urine sample; rarely a random urine sample

Test Preparation Needed?

You may be instructed to avoid certain foods and medications prior to this test.

The Test Sample

What is being tested?

This test measures the amount of 5-hydroxyindoleacetic acid (5-HIAA) in the urine. 5-HIAA is the primary metabolite of serotonin, a derived from the amino acid tryptophan. Serotonin is produced as needed by the nervous system, mainly the brain, but also special cells in the bronchial tubes (lungs) and gastrointestinal (GI) tract. It helps transmit nerve impulses and constrict blood vessels, participates in the wake-sleep cycle, and affects mood. After it is used by the body, serotonin is broken down in the liver, and its metabolites, including 5-HIAA, are excreted in the urine.

Ordinarily, only small varying amounts of 5-HIAA are present in the urine. Large quantities of serotonin and 5-HIAA may be produced, however, by some carcinoid tumors. Carcinoid tumors are slow-growing noncancerous or cancerous neuroendocrine masses that can form in the GI tract, on the appendix, and in the lungs. About 2 out of every 3 carcinoids are found in the GI tract with most of the rest occurring in the lungs, though they may affect other organs as well. According to the American Cancer Society, there are about 11,000 to 12,000 neuroendocrine tumors or cancers diagnosed each year in United States. Many more of these tumors may exist, but most remain small and do not cause any symptoms. When carcinoid tumors are discovered in asymptomatic patients during surgical procedures performed for other reasons, they are called "incidental" tumors. A small percentage of these tumors may eventually grow large enough to cause obstructions in the intestines or bronchial tubes of the lungs.

About 10% of carcinoid tumors, primarily those found in the GI tract with liver involvement, will produce enough serotonin to cause symptoms, such as flushing of the face, diarrhea, a rapid heart rate, and wheezing, which are referred to as carcinoid syndrome. The serotonin that causes carcinoid syndrome may be released continuously or intermittently and can lead to significantly increased quantities of 5-HIAA in the urine.

How is the sample collected for testing?

For the 24-hour urine collection, all of the urine should be saved for a 24-hour period. It is best to keep the sample in a cool, dark place, such as a refrigerator.

Is any test preparation needed to ensure the quality of the sample?

Pre-sample preparation is important for accurate 5-HIAA test results. Foods such as avocados, bananas, pineapples, plums, walnuts, tomatoes, kiwi fruit, and eggplant can interfere with 5-HIAA measurement and should be avoided for 3 days prior to and during urine collection. There are also a variety of drugs that can affect the 5-HIAA test, but you should talk to your doctor before decreasing or discontinuing any medications.

The Test

How is it used?

5-HIAA may be ordered by itself or along with a blood serotonin level to help diagnose and monitor carcinoid tumors. A 24-hour urine sample is preferred for the 5-HIAA test because the metabolite level in the urine can vary during the day. A random urine sample is sometimes tested, usually along with a urine creatinine level, when a 24-hour sample is not feasible. The random sample is not as accurate, however, and if the excess 5-HIAA is released intermittently, then it may be missed.

When is it ordered?

This test is primarily ordered when a person has symptoms suggestive of a carcinoid tumor.

Examples of symptoms include:

Flushing of the face and neck (appearance of deep red color, usually with sudden onset)
Diarrhea, nausea, vomiting
Rapid heart rate
Wheezing, coughing, difficulty breathing

This test may also be ordered at intervals to help monitor the effectiveness of treatment in people who have been diagnosed with and treated for a serotonin-secreting carcinoid tumor.

What does the test result mean?

A significantly increased level of 5-HIAA in a 24-hour urine sample in a person with carcinoid syndrome symptoms is suggestive but not diagnostic of a carcinoid tumor. In order to diagnose the condition, the tumor itself must be located and a sample of it examined (). The doctor will frequently follow an abnormal test result with an order for an imaging scan to help locate any tumor(s) that may be present.

Someone with symptoms may still have a carcinoid tumor even if the concentration of 5-HIAA is normal. The person may have a tumor that does not secrete serotonin or one that secretes it intermittently. A person with no symptoms and normal levels of 5-HIAA is unlikely to have a serotonin-secreting carcinoid tumor.

In those who are being monitored following treatment for carcinoid tumor, decreasing levels of 5-HIAA indicate a response to treatment, while increasing or continued excessive concentrations indicate that the treatment has not been successful.

Is there anything else I should know?

There are a variety of drugs that can affect the 5-HIAA test. Medications that can increase 5-HIAA include acetaminophen, caffeine, ephedrine, diazepam (Valium), nicotine, glyceryl guaiacolate (an ingredient found in some cough medicines), and phenobarbital. Medications that can decrease 5-HIAA include aspirin, ethyl alcohol, imipramine, levodopa, MAO inhibitors, heparin, isoniazid, methyldopa, and tricyclic antidepressants. People should talk to their doctor before decreasing or discontinuing any medications.

Common Questions

Why do I have to collect my urine for 24 hours?

The concentration of 5-HIAA in the urine varies throughout the day. By collecting all urine for 24 hours, the amount of 5-HIAA in the urine can be averaged over the entire day and increases of 5-HIAA will be detected more easily than in a single random urine sample.

Are there other metabolites of serotonin?

Yes, the other major metabolite is 5-hydroxytryptphol (5-HTOL). This substance is not routinely tested for but may sometimes be performed in a ratio with the 5-HIAA test to evaluate ethyl alcohol ingestion. An increased ratio of 5-HTOL/5-HIAA can be indicative of alcohol consumption in both living people and postmortem.

Will my results be accurate if I must continue to take my medication?

If the drug is one that can increase or decrease the amount of serotonin and 5-HIAA, then your results may be affected. However, it is up to your doctor and you to decide whether or not your medication can be safely stopped prior to and during the test collection. If your drugs must be taken, then your doctor will interpret the test results with this in mind.

Are some people at a higher risk for developing a carcinoid tumor?

Anyone at any age can develop a carcinoid tumor but, according to the American Cancer Society, the average age at diagnosis is usually about 55 to 65. People with a family history of multiple endocrine neoplasia (MEN1), a genetic condition that increases a person's risk of developing tumors in the endocrine system glands, may be at higher risk for developing a carcinoid tumor.

On This Site

Conditions: Endocrine System and Syndromes

Elsewhere On The Web

The Carcinoid Cancer Foundation, Inc.
Caring for Carcinoid Foundation
American Cancer Society: Gastrointestinal Carcinoid Tumors, A Detailed Guide
National Cancer Institute: Gastrointestinal Carcinoid Tumors Treatment (PDQ®)
CarcinoidLink: Diagnosis of Carcinoid Syndrome

NOTE: Pages listed here are provided as supplemental resources for your further research. For a complete list of sources used in preparing this article, click here.

Article Sources

NOTE: This article is based on research that utilizes the sources cited here as well as the collective experience of the Lab Tests Online Editorial Review Board. This article is periodically reviewed by the Editorial Board and may be updated as a result of the review. Any new sources cited will be added to the list and distinguished from the original sources used.

Sources Used in Current Review

Dugdale, D. (2008 November 10). 5-HIAA. MedLinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003612.htm. Accessed July 2010.

(Revised 2009 June 06). Detailed Guide: Gastrointestinal Carcinoid Tumors. American Cancer Society [On-line information]. Available online at http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?rnav=cridg&dt=14 through http://www.cancer.org. Accessed July 2010.

(Revised 2010 March 18). Detailed Guide: Lung Carcinoid Tumor. American Cancer Society [On-line information]. Available online at http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?rnav=cridg&dt=56 through http://www.cancer.org. Accessed July 2010.

(2010 February). Carcinoid Tumor. Cancer.Net, American Society of Clinical Oncology [On-line information]. Available online at http://www.cancer.net/patient/Cancer+Types/Carcinoid+Tumor through http://www.cancer.net. Accessed July 2010.

(Modified 2008 May 16) Gastrointestinal Carcinoid Tumors Treatment (PDQ®), Health Professional Version [On-line information]. Available online at http://www.cancer.gov/cancertopics/pdq/treatment/gastrointestinalcarcinoid/HealthProfessional through http://www.cancer.gov. Accessed July 2010.

Santacroce, L. and Diomede, L. (Updated 2009 November 19). Malignant Carcinoid Syndrome. eMedicine [On-line information]. Available online at http://emedicine.medscape.com/article/282515-overview through http://emedicine.medscape.com. Accessed July 2010.

Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL eds (2005). Harrison's Principles of Internal Medicine, 16th Edition, McGraw Hill, Pp 2224-2225.

Sources Used in Previous Reviews

Thomas, Clayton L., Editor (1997). Taber's Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].

Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby's Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO. Pp 497-498.

(2005). Gastrointestinal Carcinoid Tumors, A Detailed Guide. American Cancer Society [On-line information]. Available online at http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=14 through http://www.cancer.org.

Nanda, R. (2005 April 15, Updated). 5-HIAA. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003612.htm.

Brose, M. (2004 August 3, Updated). Carcinoid Syndrome. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/000347.htm.

Zuetenhorst, J. et. al. (2004 July 9). Daily Cyclic Changes in the Urinary Excretion of 5-Hydroxyindoleacetic Acid in Patients with Carcinoid Tumors. Clinical Chemistry [On-line journal]. Available online at http://www.clinchem.org/cgi/content/full/50/9/1634 through http://www.clinchem.org.

(© 2006). 5-Hydroxyindoleacetic Acid (HIAA), Urine. ARUP's Guide to Clinical Laboratory Testing [On-line information]. Available online at http://www.aruplab.com/guides/clt/tests/clt_a349.jsp#1152320 through http://www.aruplab.com.

Datta, V. (2005 May 17, Updated). Serum serotonin level. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003562.htm.

Sweeney, J. and Rosemurgy, A. (1997 January/February). Carcinoid Tumors of the Gut. Cancer Control Journal v4 (1) [On-line journal]. Available online at https://www.moffitt.usf.edu/pubs/ccj/v4n1/article2.htm through https://www.moffitt.usf.edu.

Strosberg, J. et. al. (2006 January). Selective Hepatic Artery Embolization for Treatment of Patients With Metastatic Carcinoid and Pancreatic Endocrine Tumors. Cancer Control Journal v13 (1) [On-line journal]. Available online at https://www.moffitt.usf.edu/pubs/ccj/ through https://www.moffitt.usf.edu.

Johnson, R. et. al. (2003 November). Ethanol Origin in Postmortem Urine: A LC/MS Determination of Serotonin Metabolites. Federal Aviation Administration [On-line Medicine Technical Report]. Available online through http://www.faa.gov